The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients (pts) with cholangiocarcinoma (CCA) before and during adjuvant chemotherapy (ACT): Sub-analysis of the randomized phase 2 STAMP trial.
 
Changhoon Yoo
Honoraria - AstraZeneca; Bayer; Boryung Pharmaceuticals; Bristol-Myers Squibb; Celgene; Eisai; Ipsen; MSD Oncology; Novartis; SERVIER
Research Funding - AstraZeneca; Bayer; SERVIER
 
George Laliotis
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Hyehyun Jeong
No Relationships to Disclose
 
Jae Ho Jeong
Honoraria - Boryung; inno.N; Novartis; Pfizer
Consulting or Advisory Role - Boryung; Eisai; Hanmi; Pfizer
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech
 
Seonmin Lee
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Shruti Sharma
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Punashi Dutta
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Meenakshi Malhotra
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Adham A Jurdi
Employment - Natera
Stock and Other Ownership Interests - Cardiff Oncology; natera
Speakers' Bureau - Natera
Travel, Accommodations, Expenses - Natera
 
Minetta Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - AstraZeneca; Genomic Health; Ionis Pharmaceuticals